ProfileGDS5678 / 1453868_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 32% 32% 32% 31% 32% 32% 31% 31% 31% 32% 32% 32% 32% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7643532
GSM967853U87-EV human glioblastoma xenograft - Control 22.7310932
GSM967854U87-EV human glioblastoma xenograft - Control 32.7349432
GSM967855U87-EV human glioblastoma xenograft - Control 42.6563531
GSM967856U87-EV human glioblastoma xenograft - Control 52.6697632
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.8121832
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.764431
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6870831
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6917431
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.7148632
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.7151632
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.694332
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.7212332
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.706831